Unlocking Safe Reprogramming with Deep Learning

Add to your list(s) Download to your calendar using vCal

• Brendan Swain - Shift Bioscience
• Tuesday 21 November 2023, 17:30-18:30
• Bristol Myers-Squibb lecture theatre Department of Chemistry, Lensfield Rd, Cambridge, CB2 1EW.

If you have a question about this talk, please contact Brandon Spencer Lockey.

⭐️Abstract⭐️ Brendan Swain serves as the Chief Scientific Officer (CSO) and co-founder of Shift Bioscience, a pioneering biotechnology company focused on cellular reprogramming to treat age-related diseases 🧬

Shift is using active machine learning 💻 combined with in vitro and in silico perturbation experiments to find gene combinations that safely reprogram cells to a youthful state. Shift hopes to use these genes to treat multiple diseases simultaneously and have a significant impact on human health.

This talk is part of the Cambridge University Longevity Society 2023-2024 Series series.

This talk is included in these lists:

• Biology
• Bristol Myers-Squibb lecture theatre Department of Chemistry, Lensfield Rd, Cambridge, CB2 1EW
• Cambridge Neuroscience Seminars
• Cambridge University Longevity Society 2023-2024 Series
• Cambridge talks
• Chris Davis' list
• Featured lists
• Life Science
• Life Sciences
• Neuroscience
• Neuroscience Seminars
• Neuroscience Seminars
• Stem Cells & Regenerative Medicine
• dh539

Note that ex-directory lists are not shown.